Healthcare AI Impact News
- AstraZeneca + Modella AI (2026): AstraZeneca acquired Boston-based Modella AI to bring AI-driven pathology and biomarker discovery in-house for oncology research.
- GE HealthCare + Intelerad (Expected H1 2026): GE HealthCare announced plans to acquire medical imaging software provider Intelerad for approximately $2.3 billion.
- Eli Lilly’s "LillyPod" (2026): Eli Lilly inaugurated the world’s first pharmaceutical AI supercomputer powered by 1,016 NVIDIA Blackwell GPUs to accelerate drug discovery and genomics.
- Siemens Magnetom Flow (Jan 2026): Siemens Healthineers received FDA clearance for this 1.5T MRI system, which uses "Deep Resolve" AI to reduce scan times and "myExam Autopilot" for automated workflows.
- AVI AI Technologies (March 2026): AVI Polymers launched this new subsidiary to focus on AI-driven personal healthcare solutions and dashboards in the Indian marke
- Scale Over Pilots: By 2026, industry experts expect "AI credibility" to depend on proven ROI rather than experimentation, with ambient clinical documentation reaching near-universal penetration in acute care
- Stryker + Care.ai (2024): Stryker acquired Care.ai to move into "ambient intelligence," using computer vision to monitor patient safety in hospital rooms.
- Aidoc CARE1™ Foundation Model (2025): Aidoc received the first-ever FDA clearance for a clinical AI device powered by a foundation model, initially focused on rib fracture triage